Back to School for Biotech
How Academia and Industry Can Collaborate to Advance Biologic Drug Development and Manufacturing
The Shifting Field of Stem Cell Regulations
Recent FDA Hearings Addressed Concerns Around Clinics Offering Cellular Therapies to Consumers
Enhancing Graduate and Postdoc Education for a Sustainable Workforce
Ph.D.-Trained Biomedical Scientists Can No Longer Count on Finding Academic Positions Upon Graduation
Unlucky 13: Top Clinical Trial Failures of 2016
In Missing Primary Endpoints, These Drugs Touched Off Stock Selloff, Layoffs, and Worse
For full access to this article login to GEN Select now.
Reprogramming Alters Cells’ Fate
- The electrifying possibility of reprogramming human cells to different fates has huge ramifications for human therapeutics. The technology is gaining momentum as scientists make headway to better understand the molecular and cellular aspects of reprogramming. Some of these new and emerging strategies were showcased at Gordon Conference’s recent ...
Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.
Get GEN Select Access Now
- Do not put any letters or characters here if you are not a spy program.